Healthcare provider profile · identity verified

Jorge Lopez, FNP

Nurse Practitioner · HIALEAH, FL · NPI 1336633320

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	259	80
Gabapentin	Gabapentin	178	60
Rosuvastatin Calcium	Rosuvastatin Calcium	167	50
Losartan Potassium	Losartan Potassium	154	52
Diclofenac Sodium	Diclofenac Sodium	146	41
Levothyroxine Sodium	Levothyroxine Sodium	144	38
Trazodone Hcl	Trazodone Hcl	130	38
Pantoprazole Sodium	Pantoprazole Sodium	126	34
Albuterol Sulfate Hfa	Albuterol Sulfate	124	40
Quetiapine Fumarate	Quetiapine Fumarate	124	29
Famotidine	Famotidine	121	33
Omeprazole	Omeprazole	116	39
Furosemide	Furosemide	113	38
Fluticasone Propionate	Fluticasone Propionate	109	38
Metformin Hcl	Metformin Hcl	98	30
Donepezil Hcl	Donepezil Hcl	94	25
Tamsulosin Hcl	Tamsulosin Hcl	93	28
Linzess	Linaclotide	92	18
Amlodipine Besylate	Amlodipine Besylate	90	28
Lisinopril	Lisinopril	88	30
Montelukast Sodium	Montelukast Sodium	88	31
Clopidogrel	Clopidogrel Bisulfate	84	23
Metoprolol Succinate	Metoprolol Succinate	82	26
Azithromycin	Azithromycin	80	59
Ketoconazole	Ketoconazole	80	21
Escitalopram Oxalate	Escitalopram Oxalate	79	23
Mupirocin	Mupirocin	76	41
Sertraline Hcl	Sertraline Hcl	75	24
Eliquis	Apixaban	73	19
Metoprolol Tartrate	Metoprolol Tartrate	73	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	71	56
Ammonium Lactate	Ammonium Lactate	69	26
Memantine Hcl	Memantine Hcl	67	20
Ibuprofen	Ibuprofen	66	21
Ssd	Silver Sulfadiazine	65	19
Dicyclomine Hcl	Dicyclomine Hcl	63	15
Temazepam	Temazepam	63	11
Nifedipine Er	Nifedipine	62	19
Tramadol Hcl	Tramadol Hcl	62	27
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	61	22
Hydrochlorothiazide	Hydrochlorothiazide	57	19
Potassium Chloride	Potassium Chloride	56	18
Diclofenac Sodium Er	Diclofenac Sodium	54	13
Ozempic	Semaglutide	53	11
Prednisone	Prednisone	53	39
Meclizine Hcl	Meclizine Hcl	52	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Lorazepam	Lorazepam	49	11
Mirtazapine	Mirtazapine	49	16
Baclofen	Baclofen	47	28
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	47	22
Bumetanide	Bumetanide	46	13
Alendronate Sodium	Alendronate Sodium	43	13
Naproxen	Naproxen	43	11
Levofloxacin	Levofloxacin	42	34
Carvedilol	Carvedilol	39	14
Meloxicam	Meloxicam	39	11
Metformin Hcl Er	Metformin Hcl	39	12
Nystatin	Nystatin	39	20
Alprazolam	Alprazolam	37	suppressed
Finasteride	Finasteride	36	suppressed
Megestrol Acetate	Megestrol Acetate	36	11
Methylprednisolone	Methylprednisolone	35	31
Latanoprost	Latanoprost	34	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Hydrocortisone	Hydrocortisone	33	13
Duloxetine Hcl	Duloxetine Hcl	32	11
Ondansetron Odt	Ondansetron	32	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Vascepa	Icosapent Ethyl	31	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	15
Enalapril Maleate	Enalapril Maleate	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Gemtesa	Vibegron	26	suppressed
Lactulose	Lactulose	26	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	12
Entresto	Sacubitril/Valsartan	25	suppressed
Nystop	Nystatin	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Glipizide	Glipizide	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Atenolol	Atenolol	23	suppressed
Methenamine Hippurate	Methenamine Hippurate	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	12
Trulicity	Dulaglutide	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	19	suppressed
Dutasteride	Dutasteride	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	19	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	19	suppressed
Brilinta	Ticagrelor	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Irbesartan	Irbesartan	18	suppressed
Restasis	Cyclosporine	18	suppressed
Topiramate	Topiramate	18	suppressed
Valsartan	Valsartan	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Atrovent Hfa	Ipratropium Bromide	17	suppressed
Cefdinir	Cefdinir	17	suppressed
Cephalexin	Cephalexin	17	16
Ciclopirox	Ciclopirox Olamine	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Nyamyc	Nystatin	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	11
Cyclosporine	Cyclosporine	15	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Rivastigmine	Rivastigmine	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Calcium Acetate	Calcium Acetate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Estradiol	Estradiol	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	11	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	11
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error